Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.
) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day down 2.0%. By the end of trading, Forest Laboratories fell $1.15 (-1.2%) to $91.30 on light volume. Throughout the day, 1,614,667 shares of Forest Laboratories exchanged hands as compared to its average daily volume of 3,856,700 shares. The stock ranged in price between $91.29-$93.67 after having opened the day at $92.69 as compared to the previous trading day's close of $92.45. Other companies within the Health Care sector that declined today were:
), down 39.4%,
), down 19.3%,
), down 15.2% and
), down 13.1%.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass
Forest Laboratories, Inc. develops, manufactures, and sells branded forms of ethical drug products in the United States and Europe. Forest Laboratories has a market cap of $25.1 billion and is part of the drugs industry. Shares are up 54.0% year to date as of the close of trading on Tuesday. Currently there are 9 analysts that rate Forest Laboratories a buy, no analysts rate it a sell, and 14 rate it a hold.
TheStreet Ratings rates
. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, compelling growth in net income, good cash flow from operations and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.
- You can view the full Forest Laboratories Ratings Report.
On the positive front,
), up 17.4%,
), up 12.6%,
), up 11.6% and
), up 6.2% , were all gainers within the health care sector with
) being today's featured health care sector leader.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider
) while those bearish on the health care sector could consider
- Find other investment ideas from our top rated ETFs lists.